Center for Scientific Review; Notice of Closed Meetings

Download PDF
Federal RegisterOct 25, 2024
89 Fed. Reg. 85222 (Oct. 25, 2024)
Document Headings

Document headings vary by document type but may contain the following:

  • the agency or agencies that issued and signed a document
  • the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to
  • the agency docket number / agency internal file number
  • the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions
  • See the Document Drafting Handbook for more details.

    Department of Health and Human Services National Institutes of Health

    Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Epidemiology and Population Health.

    Date: November 20, 2024.

    Time: 10 a.m. to 2 p.m.

    Agenda: To review and evaluate grant applications.

    Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

    Meeting Format: Virtual Meeting.

    Contact Person: Cynthia C. McOliver, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 1007G, Bethesda, MD 20892, (301) 594-2081 mcolivercc@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis Panel; BBBT Small Business: Biomaterials, Delivery, and Nanotechnology.

    Date: November 21-22, 2024.

    Time: 8 a.m. to 6 p.m.

    Agenda: To review and evaluate grant applications.

    Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

    Meeting Format: Virtual Meeting.

    Contact Person: David R. Filpula, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6181, MSC 7892, Bethesda, MD 20892, 301-435-2902, filpuladr@mail.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Clinical Neurophysiology, Devices, Neuroprosthetics and Biosensors.

    Date: November 21-22, 2024.

    Time: 8:30 a.m. to 7 p.m.

    Agenda: To review and evaluate grant applications.

    Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

    Meeting Format: Virtual Meeting.

    Contact Person: Cristina Backman, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5211, MSC 7846, Bethesda, MD 20892, (301) 480-9069, cbackman@mail.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis Panel; Small Business: Aging and Development, Auditory Vision and Low Vision Technologies.

    Date: November 21-22, 2024.

    Time: 9 a.m. to 7 p.m.

    Agenda: To review and evaluate grant applications.

    Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

    Meeting Format: Virtual Meeting.

    Contact Person: Barbara Susanne Mallon, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480-8992 mallonb@mail.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis Panel; Topics in Health Services Research, Maternal and Child Health, Aging, and Substance Use.

    Date: November 21-22, 2024.

    Time: 9 a.m. to 6 p.m.

    Agenda: To review and evaluate grant applications.

    Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

    Meeting Format: Virtual Meeting.

    Contact Person: Deborah Leachman Quesenberry, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (423) 747-7534, quesenberrydl@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Transformative Research Award for the Include Project.

    Date: November 21, 2024.

    Time: 9 a.m. to 8 p.m.

    Agenda: To review and evaluate grant applications.

    Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

    Meeting Format: Virtual Meeting.

    Contact Person: Katherine M. Malinda, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4140, MSC 7814, Bethesda, MD 20892, (301) 435-0912 malindakm@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis Panel; Substance Use and Prevention and Treatment of Addiction.

    Date: November 21, 2024.

    Time: 9 a.m. to 7 p.m.

    Agenda: To review and evaluate grant applications.

    Address: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892.

    Meeting Format: Virtual Meeting.

    Contact Person: Jacinta Bronte-Tinkew, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3164, MSC 7770, Bethesda, MD 20892, (301) 806-0009, Jacinta.bronte-tinkew@nih.gov.

    (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS)

    Dated: October 22, 2024

    Lauren A. Fleck,

    Program Analyst, Office of Federal Advisory Committee Policy.

    [FR Doc. 2024-24882 Filed 10-24-24; 8:45 am]

    BILLING CODE 4140-01-P